Study uncovers possible path for improving T cell therapies Sept. 7, 2022 A study led by researchers at the University of Arizona Health Sciences discovered new information about the inner workings of the immune system that could have a profound impact on T cell therapies for cancer and other diseases. eCancer
How this Phoenix building was designed to combat the unforgiving heat Sept. 7, 2022 A downtown Phoenix building was designed to mitigate the effects of unforgiving summer temperatures. KJZZ-FM (Phoenix, AZ)
The updated COVID-19 boosters were authorized and released before testing on people Sept. 7, 2022 The new round of COVID-19 booster shots, reformulated to target the BA.4 and BA.5 omicron subvariants as well as the original strain of COVID, are the first shots to be distributed prior to human trials. Health
Study Uncovers Possible Path for Improving T Cell Therapies Sept. 6, 2022 Researchers studied the evolution of the immune system to find a new way to activate T cells to fight infection and disease. Read more Image
Recent Advances in Phototherapy for Pain Sept. 6, 2022 Dr. Mohab Ibrahim will discuss scientific evidence behind phototherapy, research discoveries related to pain and possible mechanisms of action. Read more Image
Helping People SIFT Through Misinformation Sept. 6, 2022 Public Health’s Loren Halili says using "living room language" and listening to people’s fears are useful tools when confronting false information. Read more Image
Are vasectomies reversible? Sept. 6, 2022 When the Supreme Court’s decision to overturn Roe v. Wade was leaked in May, average daily online searches for the term “vasectomy” nearly doubled, according to Innerbody Research. The New York Times
Valley fever vaccine still years away Sept. 6, 2022 Valley fever is a disease caused by fungal spores that live in the desert dirt. Scientists have been looking for a vaccine for 60 years. KPNX-TV (Phoenix, AZ)
What protection to expect from updated COVID vaccines this fall Sept. 3, 2022 Canada approved an updated COVID-19 vaccine to target the highly contagious omicron variant BA.1, with doses expected to start rolling out within days. CBC News (Canada)